via caring.com
In an interesting development the Statin cholesterol lowering group of drugs is showing some effect at reducing the progression of MS suggesting that MS may be linked to lipid metabolism?
It included 81 patients with early-stage MS randomly selected to take either 80 milligrams a day of Lipitor (atorvastatin) or a placebo. After 12 months of treatment, 55.3 percent of patients taking the drug had developed no new brain lesions, compared with 27.6 percent of those who took the placebo.
While early results needing more study it does offer some promise of a treatment
